R07.F RUBICON ORGANICS INC

Healthcare Pharmaceuticals Frankfurt Exchange
0.2580 EUR
Close of Nov 12, 2026
0.2180 0.3540
Market cap
EUR 17.4M
P/E
-
P/B
0.63x
ROE
-11.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is R07.F undervalued?

Graham number

The Graham number of RUBICON ORGANICS INC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RUBICON ORGANICS INC fundamental analysis

No fundamental analysis for RUBICON ORGANICS INC yet.

RUBICON ORGANICS INC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RUBICON ORGANICS INC

Rubicon Organics Inc., together with its subsidiaries, engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally. The company offers cannabis products in dried flower, pre-rolls, concentrates, gummies, capsules, edibles, vapes, topicals, relief sticks, and oils. It sells its products under the Simply Bare Organic, 1964 Supply Co, Homestead Cannabis Supply, and Wildflower brand names. The com…

Full company profile